CureVac N.V.
CVACNASDAQHealthcare
$4.66
+$0.00(+0.00%)
Market Cap$1.0B
P/E Ratio—
52W High$5.72
52W Low$2.475
CureVac N.V. (CVAC) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CVAC · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.19B | ($0.26B) | ($0.25B) | ($0.41B) | ($0.13B) |
| Depreciation & Amort. | $0.02B | $0.02B | $0.02B | $0.02B | $0.01B |
| Stock-Based Comp. | $0.00B | $0.01B | $0.01B | $0.01B | $0.01B |
| Change in Working Capital | ($0.16B) | ($0.07B) | ($0.13B) | ($0.07B) | $0.58B |
| Net Cash from Operations | $0.10B | ($0.27B) | ($0.29B) | ($0.73B) | $0.52B |
| Investing Activities | |||||
| Capital Expenditure | ($0.02B) | ($0.06B) | ($0.09B) | ($0.13B) | ($0.05B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.02B) | ($0.06B) | ($0.09B) | ($0.13B) | ($0.05B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | ($0.03B) | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.01B) | ($0.01B) | ($0.00B) | ($0.03B) | ($0.05B) |
| Net Cash from Financing | ($0.01B) | $0.23B | $0.06B | $0.34B | $0.82B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.08B | ($0.32B) | ($0.38B) | ($0.86B) | $0.48B |
| FCF Margin %(computed) | 15.58% | -601.00% | -562.74% | -836.03% | 971.47% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · EUR · B
Explore more CureVac N.V. data
About CureVac N.V. (CVAC) Cash Flow Statement
CureVac N.V. generated operating cash flow of $0.10B and free cash flow of $0.08B for 2024 — a FCF margin of 15.58%. Capital expenditure was ($0.02B).
Frequently asked questions
CVAC · 4 questionsCureVac N.V. generated free cash flow of $0.08B for 2024, up 125.8% year-over-year.
CVAC free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10